Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01228344
Recruitment Status : Completed
First Posted : October 26, 2010
Last Update Posted : April 7, 2017
Centers for Disease Control and Prevention
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 30, 2015
  Actual Study Completion Date : September 30, 2015